Zomedica To Take Control Of Aspects Of TRUFORMA Product Line Previously Provided By Qorvo
Under the agreements, Zomedica will take control of aspects of the TRUFORMA product line previously provided by Qorvo, including development of new assays and manufacturing both instruments and assay cartridges. This
Zomedica Announced Expanded Relationship with Structured Medical Products and Begins Commercializing VetGuardian Wireless Monitors
Zomedica Corp. (NYSE American: ZOM) today announced that in cooperation with Structured Monitoring Products, Inc. (SMP), it will begin commercializing the revolutionary VetGuardian® zero-touch vital signs remote monitoring system for veterinary professionals.
Benzinga’s Top Ratings Upgrades, Downgrades For January 6, 2023
Upgrades Piper Sandler upgraded the previous rating for Aligos Therapeutics Inc (NASDAQ:ALGS) from Neutral to Overweight. Aligos Therapeutics…
Dawson James Initiates Coverage On Zomedica with Buy Rating, Announces Price Target of $6
Dawson James analyst Jason Kolbert initiates coverage on Zomedica (AMEX:ZOM) with a Buy rating and announces Price Target of $6.
Stocks That Hit 52-Week Lows On Thursday
Thursday's session saw 329 companies set new 52-week lows.
Zomedica Granted U.S. Patent #11486878 Compositions and Methods for Identifying Cancer Cells
https://www.scribd.com/document/604315145/Zomedica-Patent-11486878
This Technology Stock Jumped 55% Following Q2 Results; Here Are 96 Biggest Movers From Yesterday
Gainers
Eargo, Inc. (NASDAQ: EAR) jumped 77.2% to close at $2.02. The FDA finalized rule enabling access to over-the-counter hearing aids.
Why GreenBox POS Is Trading Higher By Around 72%, Here Are 70 Stocks Moving In Tuesday’s Mid-Day Session
Gainers
GreenBox POS (NASDAQ: GBOX) shares jumped 72.4% to $2.19 as the company reported better-than-expected Q2 sales.
Zomedica Pharmaceuticals Q2 EPS $(0.01), Same YoY, Sales $4.20M Up From $15.69K YoY
Zomedica Pharmaceuticals (AMEX:ZOM) reported quarterly losses of $(0.01) per share. This is unchanged from the same period last year. The company reported $4.20 million in sales this quarter. This is a 26.66K percent